Trial intelligence / Profile preview

Fruquintinib (AiYoute) Post-Marketing Safety Study in China

CTR20190729Phase 4Completed

Sponsor

HUTCHMED

Start

Apr 2019

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1